Delisa G. Brown

Title
InstitutionMedical University of South Carolina
DepartmentAddiction Sciences Division
AddressP.O. Box MSC 861
472 N
Psychiatric Hospital - 67 President St.
Phone843-792-2388
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Back SE, Flanagan JC, Killeen T, Saraiya TC, Brown DG, Jarnecke AM, Rothbaum AO, Joseph J, Ana ES, de Arellano A, Shoemaker HL, Dixon RA, Nietert PJ, Brady KT. COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans. Contemp Clin Trials. 2023 03; 126:107084. PMID: 36646315; PMCID: PMC9998357.
      Citations:    Fields:    Translation:Humans
    2. Saraiya TC, Jarnecke AM, Rothbaum AO, Wangelin B, McTeague LM, Acierno R, Brown DG, Bristol E, Feigl H, Reese M, Cobb AR, Harley B, Adams RJ, Back SE. Technology-enhanced in vivo exposures in Prolonged Exposure for PTSD: A pilot randomized controlled trial. J Psychiatr Res. 2022 Nov 01; 156:467-475. PMID: 36347106.
      Citations:    Fields:    
    3. Back SE, Acierno R, Saraiya TC, Harley B, Wangelin B, Jarnecke AM, McTeague LM, Brown DG, Ana ES, Rothbaum AO, Adams RJ, Back SE, Acierno R, Saraiya TC, Harley B, Wangelin B, Jarnecke AM, McTeague LM, Brown DG, Ana ES, Rothbaum AO, Adams RJ. Enhancing Prolonged Exposure therapy for PTSD using physiological biomarker-driven technology. Contemp Clin Trials Commun. 2022 Aug; 28:100940. PMID: 35664505; PMCID: PMC9160482.
      Citations:    
    4. Jarnecke AM, Saraiya TC, Brown DG, Richardson J, Killeen T, Back SE, Jarnecke AM, Saraiya TC, Brown DG, Richardson J, Killeen T, Back SE. Examining the role of social support in treatment for co-occurring substance use disorder and posttraumatic stress disorder. Addict Behav Rep. 2022 Jun; 15:100427. PMID: 35480064; PMCID: PMC9036141.
      Citations: 1     
    5. Jones JL, Barth KS, Brown DG, Halliday CA, Brady KT, Book SW, Bristol EJ, Back SE, Jones JL, Barth KS, Brown DG, Halliday CA, Brady KT, Book SW, Bristol EJ, Back SE. The Drug Abuse Research Training (DART) Program for Psychiatry Residents and Summer Fellows: 15-Year Outcomes. Acad Psychiatry. 2022 Jun; 46(3):317-324. PMID: 35113391; PMCID: PMC9232963.
      Citations:    
    6. Saraiya TC, Jarnecke AM, Jones J, Brown DG, Brady KT, Back SE, Saraiya TC, Jarnecke AM, Jones J, Brown DG, Brady KT, Back SE. Laboratory-induced stress and craving predict opioid use during follow-up among individuals with prescription opioid use disorder. Drug Alcohol Depend. 2021 08 01; 225:108755. PMID: 34052686; PMCID: PMC8282754.
      Citations:    
    7. Brown DG, Flanagan JC, Jarnecke A, Killeen TK, Back SE, Brown DG, Flanagan JC, Jarnecke A, Killeen TK, Back SE. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment. J Ethn Subst Abuse. 2022 Jul-Sep; 21(3):1141-1164. PMID: 33111647; PMCID: PMC8079537.
      Citations:    
    8. Back SE, Gray K, Santa Ana E, Jones JL, Jarnecke AM, Joseph JE, Prisciandaro J, Killeen T, Brown DG, Taimina L, Compean E, Malcolm R, Flanagan JC, Kalivas PW, Back SE, Gray K, Santa Ana E, Jones JL, Jarnecke AM, Joseph JE, Prisciandaro J, Killeen T, Brown DG, Taimina L, Compean E, Malcolm R, Flanagan JC, Kalivas PW. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961. PMID: 32087337; PMCID: PMC7333883.
      Citations:    
    9. Teeters JB, Lancaster CL, Brown DG, Back SE, Teeters JB, Lancaster CL, Brown DG, Back SE. Substance use disorders in military veterans: prevalence and treatment challenges. Subst Abuse Rehabil. 2017; 8:69-77. PMID: 28919834; PMCID: PMC5587184.
      Citations:    
    10. Tolliver BK, Desantis SM, Brown DG, Prisciandaro JJ, Brady KT, Tolliver BK, Desantis SM, Brown DG, Prisciandaro JJ, Brady KT. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord. 2012 Feb; 14(1):54-63. PMID: 22329472.
      Citations:    
    11. Prisciandaro JJ, DeSantis SM, Chiuzan C, Brown DG, Brady KT, Tolliver BK, Prisciandaro JJ, DeSantis SM, Chiuzan C, Brown DG, Brady KT, Tolliver BK. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Alcohol Clin Exp Res. 2012 Mar; 36(3):490-6. PMID: 21933201; PMCID: PMC3248624.
      Citations:    
    12. Prisciandaro JJ, Brown DG, Brady KT, Tolliver BK, Prisciandaro JJ, Brown DG, Brady KT, Tolliver BK. Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res. 2011 Aug 15; 188(3):361-5. PMID: 21641663; PMCID: PMC4750381.
      Citations:    
    13. Prisciandaro JJ, Rembold J, Brown DG, Brady KT, Tolliver BK, Prisciandaro JJ, Rembold J, Brown DG, Brady KT, Tolliver BK. Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):493-6. PMID: 21549529; PMCID: PMC4745117.
      Citations:    
    Brown's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (52)
    Explore
    _
    Co-Authors (20)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _